Chartwell Pharmaceuticals
Sean Cotter has extensive work experience in the pharmaceutical industry. Sean began their career at Pfizer in 2003, working in the Programme Management Office until 2006. Sean then moved on to Amgen, where they served as the Director of Risk Management from 2007 to 2014. In 2015, they joined Mallinckrodt Pharmaceuticals as the Senior Director of Strategic Enterprise Risk Management. Most recently, Sean worked at Chartwell Pharmaceuticals as the Executive Vice President of Corporate Quality starting in 2017.
Sean Cotter holds a PhD in Organic Chemistry from University College Cork. Sean also has a Masters degree in Financial Risk Management from NYU Stern School of Business. Furthermore, they obtained a Masters degree in Technology Management from University College Dublin.